1. Home
  2. BCAB vs STRW Comparison

BCAB vs STRW Comparison

Compare BCAB & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • STRW
  • Stock Information
  • Founded
  • BCAB 2007
  • STRW 2015
  • Country
  • BCAB United States
  • STRW United States
  • Employees
  • BCAB N/A
  • STRW N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • STRW Real Estate Investment Trusts
  • Sector
  • BCAB Health Care
  • STRW Real Estate
  • Exchange
  • BCAB Nasdaq
  • STRW Nasdaq
  • Market Cap
  • BCAB 96.2M
  • STRW 79.7M
  • IPO Year
  • BCAB 2020
  • STRW N/A
  • Fundamental
  • Price
  • BCAB $2.08
  • STRW $12.52
  • Analyst Decision
  • BCAB Strong Buy
  • STRW Strong Buy
  • Analyst Count
  • BCAB 2
  • STRW 1
  • Target Price
  • BCAB $6.00
  • STRW $10.00
  • AVG Volume (30 Days)
  • BCAB 1.6M
  • STRW 14.4K
  • Earning Date
  • BCAB 11-08-2024
  • STRW 11-11-2024
  • Dividend Yield
  • BCAB N/A
  • STRW 4.11%
  • EPS Growth
  • BCAB N/A
  • STRW N/A
  • EPS
  • BCAB N/A
  • STRW 0.47
  • Revenue
  • BCAB N/A
  • STRW $108,357,000.00
  • Revenue This Year
  • BCAB N/A
  • STRW N/A
  • Revenue Next Year
  • BCAB N/A
  • STRW N/A
  • P/E Ratio
  • BCAB N/A
  • STRW $27.19
  • Revenue Growth
  • BCAB N/A
  • STRW 12.45
  • 52 Week Low
  • BCAB $1.14
  • STRW $6.56
  • 52 Week High
  • BCAB $4.02
  • STRW $12.90
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 55.80
  • STRW 62.39
  • Support Level
  • BCAB $1.87
  • STRW $11.57
  • Resistance Level
  • BCAB $2.13
  • STRW $12.36
  • Average True Range (ATR)
  • BCAB 0.12
  • STRW 0.32
  • MACD
  • BCAB 0.00
  • STRW 0.05
  • Stochastic Oscillator
  • BCAB 68.90
  • STRW 93.10

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About STRW Strawberry Fields REIT Inc.

Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.

Share on Social Networks: